Related Experiment Video
Updated: Sep 15, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Incidence and Risk Factors for Serious Infections in Patients with Neuromyelitis Optica Spectrum Disorder: A Claims
Noriko Isobe1, Tetsuro Oda2, Tomohiro Yamaguchi2
1Department of Neurology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. isobe.noriko.342@m.kyushu-u.ac.jp.
Serious infections are a significant concern for patients with neuromyelitis optica spectrum disorder (NMOSD). This study identified key risk factors, including older age and specific comorbidities, to aid in patient management and treatment decisions.
Area of Science:
- Neurology
- Immunology
- Infectious Disease Epidemiology
Background:
- Serious infections represent a primary cause of mortality in patients diagnosed with neuromyelitis optica spectrum disorder (NMOSD).
- Understanding the incidence and risk factors for these infections is crucial for improving patient outcomes.
Purpose of the Study:
- To determine the incidence rate and cumulative incidence of serious infections in a large cohort of NMOSD patients in Japan.
- To identify and analyze potential risk factors associated with the development of serious infections in this population.
Main Methods:
- An observational, retrospective cohort study utilizing the Medical Data Vision database in Japan.
- Inclusion criteria: NMOSD diagnosis between January 2016 and August 2022.
- Serious infections defined as infections diagnosed during hospitalization; Cox proportional hazard models used for risk factor analysis.
Main Results:
- The incidence rate of serious infections was 5.77 per 100 person-years.
- Cumulative incidence reached 12.48% at 5-year follow-up.
- Significant risk factors included advanced age (≥75 years), cancer, diabetes mellitus, neurogenic bladder, urolithiasis, increased NMOSD relapses, and low-dose oral glucocorticoid use.
Conclusions:
- The incidence of serious infections in NMOSD patients treated with conventional therapies is comparable to findings from clinical trials.
- Several risk factors were identified, providing valuable information for clinical decision-making.
- These findings can help clinicians and patients better manage treatment options and mitigate infection risks.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Nephrotic Syndrome II : Assessment and Medical Management
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

